Drug details

Focinvez (fosaprepitant injection)

type of Antiemetic Agents, NK1 Receptor Antagonists

Focinvez (fosaprepitant injection) is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated in adults and pediatric patients 6 months of age and older, in combination with other antiemetic agents, for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin and for prevention of delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).

This drug may have the following side effects:

• diarrhea,
• fatigue,
• indigestion,
• low white blood cells (neutropenia, leukopenia),
• weakness/lethargy
• anemia,
• numbness and tingling in extremities,
• urinary tract infection (UTI), and
• pain in extremities.

The following drugs are related to Focinvez, either as a replacement or used together:

• Anzemet Injection (dolasetron mesylate injection)
• Anzemet Tablets (dolasetron)
• Emend Injection (fosaprepitant dimeglumine injection)
• Kytril (granisetron)
• Kytril Injection (granisetron hydrochloride)
• Zofran Injection (ondansetron hydrochloride injection)
• Zofran (ondansetron hydrochloride tablets and solution)